Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2012040223) METHOD FOR TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND TYPE-II DIABETES
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2012/040223 International Application No.: PCT/US2011/052390
Publication Date: 29.03.2012 International Filing Date: 20.09.2011
IPC:
C12N 5/00 (2006.01) ,C12N 5/02 (2006.01)
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
02
Propagation of single cells or cells in suspension; Maintenance thereof; Culture media therefor
Applicants:
SEXTON, Jonathan, Z. [US/US]; US (UsOnly)
BRENMAN, Jay [US/US]; US (UsOnly)
NORTH CAROLINA CENTRAL UNIVERSITY [US/US]; 1801 Fayetteville Street Durham, NC 27707, US (AllExceptUS)
Inventors:
SEXTON, Jonathan, Z.; US
BRENMAN, Jay; US
Agent:
CORD, Janet, I.; Ladas & Parry LLP 1040 Avenue of the Americas New York, NY 10018-3738, US
Priority Data:
61/385,14621.09.2010US
Title (EN) METHOD FOR TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND TYPE-II DIABETES
(FR) PROCÉDÉ DE TRAITEMENT DE LA STÉATOSE HÉPATIQUE NON ALCOOLIQUE ET DU DIABÈTE DE TYPE II
Abstract:
(EN) This relates generally to compounds that can be used to treat nonalcoholic fatty liver disease and type II diabetes and an assay for identifying the compounds. The invention also relates to an assay that can be used to identify compounds that increase cellular peroxisomal mass.
(FR) La présente invention concerne de manière générale des composés pouvant être utilisés pour traiter la stéatose hépatique non alcoolique et le diabète de type II ainsi qu'une analyse destinée à identifier les composés. L'invention concerne également une analyse pouvant être utilisée pour identifier des composés permettant d'augmenter la masse cellulaire des peroxysomes.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)